News Daily News As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes Todd Neale September 23, 2020
News Daily News Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD Michael O'Riordan September 22, 2020
News Daily News ‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests Michael O'Riordan September 18, 2020
News Daily News ‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk Michael O'Riordan September 16, 2020
News Daily News PCI Volumes Rise in US and Japan, but for Different Reasons Michael O'Riordan September 14, 2020
News Conference News ESC 2020 New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials Caitlin E. Cox September 03, 2020
News Conference News ESC 2020 ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA Michael O'Riordan September 01, 2020
News Conference News ESC 2020 Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC Shelley Wood August 31, 2020
News Conference News ESC 2020 Updated ESC A-fib Guidance Proposes New Path for Diagnosis, Classification, and Care Shelley Wood August 30, 2020
News Daily News Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19 Michael O'Riordan August 28, 2020
News Daily News Better Outcomes, Including Mortality, With IVUS-Guided PCI: Medicare Analysis Michael O'Riordan August 18, 2020
News Daily News Should Guidelines Support TAVR for Low-Risk Patients? Two Views L.A. McKeown August 17, 2020
News Daily News Could Statins Curb Fatal or Severe COVID-19? Some Clues Michael O'Riordan August 14, 2020
News Daily News HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds Michael O'Riordan August 13, 2020
News Daily News High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention Michael O'Riordan August 11, 2020
News Daily News Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI L.A. McKeown August 10, 2020
News Daily News New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts Michael O'Riordan August 06, 2020